gastric cancer
Showing NaN - NaN of 149
Gastric Cancer, GastroEsophageal Cancer Trial in Worldwide (Bavituximab, Pembrolizumab Injection)
Active, not recruiting
- Gastric Cancer
- GastroEsophageal Cancer
- Bavituximab
- Pembrolizumab Injection
-
New Haven, Connecticut
- +20 more
Jun 14, 2022
Gastric Cancer Trial in Seoul (Patients who continued UDCA 300mg medication, Patients who discontinued UDCA 300mg prescription)
Recruiting
- Gastric Cancer
- Patients who continued UDCA 300mg medication
- Patients who discontinued UDCA 300mg prescription
-
Seoul, Korea, Republic ofDoJoong Park
Jun 6, 2022
Gastric Cancer Trial in Seoul (Variltinib, Paclitaxel)
Active, not recruiting
- Gastric Cancer
- Variltinib, Paclitaxel
-
Seoul, Korea, Republic ofYonsei University Health System, Yonsei Cancer Center
May 27, 2022
Gastric Cancer Trial in Seoul (Docetaxel (XRP6976), Oxaliplatin (SR96669), S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil +
Active, not recruiting
- Gastric Cancer
- Docetaxel (XRP6976)
- +2 more
-
Seoul, Korea, Republic ofAdministrative Office
May 3, 2022
Gastric Cancer Trial in Worldwide (Nivolumab, Tegafur-gimeracil-oteracil potassium, Oxaliplatin)
Active, not recruiting
- Gastric Cancer
- Nivolumab
- +4 more
-
Anhui Province, China
- +107 more
May 22, 2022
Gastric Cancer Trial in Korea, Republic of (FLX475, Pembrolizumab)
Recruiting
- Gastric Cancer
-
Anyang-si, Gyeonggi-do, Korea, Republic of
- +9 more
Apr 27, 2022
Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus
Terminated
- Advanced Gastrointestinal (GI) Malignancies
- +3 more
- ADI-PEG 20 plus modified FOLFOX6
-
San Francisco, California
- +34 more
Apr 18, 2022
Gastric Cancer, Diabetes, Type 2 Trial in Seoul (Long limb Roux-en-Y reconstruction after subtotal gastrectomy, Conventional
Recruiting
- Gastric Cancer
- Diabetes Mellitus, Type 2
- Long limb Roux-en-Y reconstruction after subtotal gastrectomy
- +2 more
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Apr 8, 2022
Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)
Completed
- Gastric Cancer
- Gastroesophageal Junction Cancer
- BBI608
- +2 more
-
Scottsdale, Arizona
- +262 more
Apr 4, 2022
Breast Cancer, Gastric Cancer, Gastroesophageal Junction Cancer Trial in China, Korea, Republic of, Taiwan (ZW25, Docetaxel,
Active, not recruiting
- Breast Cancer
- +2 more
- ZW25
- +4 more
-
Beijing, Beijing, China
- +21 more
Apr 1, 2022
Gastric Cancer Trial in Seoul (pembrolizumab plus ramucirumab)
Recruiting
- Gastric Cancer
- pembrolizumab plus ramucirumab
-
Seoul, Korea, Republic of
- +1 more
Feb 23, 2022
Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)
Gastric Cancer Trial in Seoul (Pembrolizumab)
Recruiting
- Gastric Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Dec 23, 2021
Gastric Cancer Trial in Japan, Korea, Republic of (TAS-118 plus Oxaliplatin, S-1 plus Cisplatin)
Completed
- Gastric Cancer
- TAS-118 plus Oxaliplatin
- S-1 plus Cisplatin
-
Ibaraki, Japan
- +5 more
Nov 10, 2021
r® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
Recruiting
- Gastric Cancer
-
Seoul, Korea, Republic ofNovomics
Oct 28, 2021
Gastric Cancer, Recurrence, Quality of Life Trial in Korea, Republic of (Computed tomography, Chest X-ray, and blood test)
Recruiting
- Gastric Cancer
- +2 more
- Computed tomography, Chest X-ray, and blood test
-
Goyang, Gyeonggi-do, Korea, Republic of
- +15 more
Oct 26, 2021
Gastric Cancer Trial in Seoul (Rhexium Onco Nutrition)
Completed
- Gastric Cancer
- Rhexium Onco Nutrition
-
Seoul, Korea, Republic ofDepartment of Surgery, Seoul National University Hospital
Oct 19, 2021
Gastric Cancer, Gastrectomy, Malnutrition Trial in Seoul (Parenteral Nutrition Solutions)
Recruiting
- Gastric Cancer
- +2 more
- Parenteral Nutrition Solutions
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 22, 2021
Gastric Cancer Trial in Seoul (da vinc SP gastrectomy)
Not yet recruiting
- Gastric Cancer
- da vinc SP gastrectomy
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Sep 10, 2021